Drug Discovery Startups in North America

There are 60 Drug Discovery digital health ventures in North America. The total venture volume has expanded at a CAGR of 6.0% over the past 5 years. The ventures have an average venture maturity score of 57.5.

In total, $4.68B of digital health venture capital has been raised across 161 funding deals.

Here is a list of 10 promising HealthTech startups!

Last Updated: January 17, 2022

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
3Scan	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	M&A	undisclosed	Toggle
Advera Health Analytics	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	M&A	undisclosed	Toggle
Alto Neuroscience	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	IPO	$ 147.90 M	Toggle
Apprentice.io	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Series C1	$ 65.00 M	Toggle
Aria Pharmaceuticals	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Grant	$ 0.23 M	Toggle
Artificial	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Series A	$ 21.50 M	Toggle
Atomwise	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Series B	$ 123.00 M	Toggle
Benchling	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Series F	$ 100.00 M	Toggle
BioAge Labs	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Series D	$ 170.00 M	Toggle
BioSymetrics	Drug Discovery	Canada	$ 123.46 B	$ 123.46 B	Series A	$ 4.88 M	Toggle

Showing 1 to 10 of 59 entries